• Biogen, ViGeneron Enter Gene Therapy Collaboration contractpharma
    January 07, 2021
    ​ViGeneron GmbH has announced a global collaboration and licensing agreement with Biogen Inc. to develop and commercialize gene therapy products based on adeno-associated virus (AAV) vectors to treat inherited eye diseases.
  • ViGeneron and WuXi Advanced Therapies Enter Partnership contractpharma
    December 03, 2020
    ​ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. have announced a strategic partnership to accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program.
PharmaSources Customer Service